Immunotherapy in patients with autoimmune disease

Immune checkpoint inhibitors (ICIs) such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 (PD-1) and programmed cell death protein ligand 1 (PD-L1) inhibitors are widely used for the treatment of multiple cancers. Seven of these agents are currently FDA approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakshit, Sagar, Molina, Julian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Contemporary Practice in Thoracic Neoplasm Diagnosis, Evaluation and Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711372/
https://www.ncbi.nlm.nih.gov/pubmed/33282408
http://dx.doi.org/10.21037/jtd-2019-cptn-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711372/
https://www.ncbi.nlm.nih.gov/pubmed/33282408
http://dx.doi.org/10.21037/jtd-2019-cptn-10

Ejemplares similares